Hepatitis B Trial, Recruiting (NCT05583006)

Hepatitis B Trial, Recruiting NCT05583006 Sponsor: Taichung Veterans General Hospital Condition: Hepatitis B

Printed from Voxsanity (voxsanity.com.au) — NCT05583006 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis B

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are at least 20 years old
People who have a detectable level of a hepatitis B protein (HBsAg) in their blood
People who have a long-term hepatitis B virus (HBV) infection and are currently being treated with a medication called entecavir (ETV)
People who are currently taking entecavir (ETV) but are not happy with how well it is working, or find it inconvenient to take
People who have no medical reasons preventing them from switching to a different hepatitis B medication called TAF (tenofovir alafenamide)
People who are expected to need hepatitis B antiviral treatment for at least another year

Who may not be able to join:

People with very advanced kidney disease (very low kidney function) who are not on dialysis
People who also have HIV, hepatitis C, or hepatitis D infection
People who currently have any active cancer
People who are currently taking medications that suppress the immune system
People who have a known allergy to medications that contain tenofovir

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Teng-Yu Lee, MD, PhD, Taichung Veterans General Hospital

Phone: +886423592525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05583006

Sponsor: Taichung Veterans General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Hepatitis B

Trial contact: +886423592525

More information: https://clinicaltrials.gov/study/NCT05583006

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are at least 20 years old
People who have a detectable level of a hepatitis B protein (HBsAg) in their blood
People who have a long-term hepatitis B virus (HBV) infection and are currently being treated with a medication called entecavir (ETV)
People who are currently taking entecavir (ETV) but are not happy with how well it is working, or find it inconvenient to take
People who have no medical reasons preventing them from switching to a different hepatitis B medication called TAF (tenofovir alafenamide)
People who are expected to need hepatitis B antiviral treatment for at least another year

Who may not be able to join:

People with very advanced kidney disease (very low kidney function) who are not on dialysis
People who also have HIV, hepatitis C, or hepatitis D infection
People who currently have any active cancer
People who are currently taking medications that suppress the immune system
People who have a known allergy to medications that contain tenofovir

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Taichung Veterans General Hospital

Registry

ClinicalTrials.gov

Start date

6 November 2023

Est. completion

30 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Rate/ concentration of renal function markers; HBV viral load; The satisfaction (including drug adherence) to TAF switch therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov